Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hitoshi Ikeda

Showing results (211-220 of 246) with videos related to

Pageof 25
Sort By:
Clinical Biochemistry|July 24, 2012
Development of an enzymatic assay for sphingomyelin with rapid and automatable performances: Analysis in healthy subjects and coronary heart disease patientsRyunosuke Ohkawa, Tatsuya Kishimoto, Makoto Kurano, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|May 28, 2014
Tumor markers are more useful in patients undergoing surveillance for hepatocellular carcinoma with unreliable results by ultrasonographyShintaro Mikami, Ryosuke Tateishi, Shu Hagiwara, et al.
Rapid Communications in Mass Spectrometry : RCM|August 15, 2019
Identification of novel biomarkers of hepatocellular carcinoma by high-definition mass spectrometry: Ultrahigh-performance liquid chromatography quadrupole time-of-flight mass spectrometry and desorption electrospray ionization mass spectrometry imagingKoshi Nagai, Baasanjav Uranbileg, Zhen Chen, et al.
Plos One|January 28, 2014
Detection of novel visible-light region absorbance peaks in the urine after alkalization in patients with alkaptonuriaYasunori Tokuhara, Kenichi Shukuya, Masami Tanaka, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 31, 2011
Prediction of hepatocellular carcinoma development by plasma ADAMTS13 in chronic hepatitis B and CHitoshi Ikeda, Ryosuke Tateishi, Kenichiro Enooku, et al.
Journal of Clinical Gastroenterology|June 20, 2007
Both plasma lysophosphatidic acid and serum autotaxin levels are increased in chronic hepatitis CNaoko Watanabe, Hitoshi Ikeda, Kazuhiro Nakamura, et al.
The EMBO Journal|June 8, 2017
Autotaxin-lysophosphatidic acid-LPA<sub>3</sub> signaling at the embryo-epithelial boundary controls decidualization pathwaysShizu Aikawa, Kuniyuki Kano, Asuka Inoue, et al.
Annals of Clinical and Translational Neurology|February 15, 2020
Nonmercaptalbumin as an oxidative stress marker in Parkinson's and PARK2 diseaseShin-Ichi Ueno, Taku Hatano, Ayami Okuzumi, et al.
Pediatric Blood & Cancer|July 4, 2025
Results of a Phase II Trial for Intermediate-Risk Rhabdomyosarcoma Treatment Protocol JRS-I: A Report From the Japan Rhabdomyosarcoma Study GroupAtsushi Kikuta, Hidekazu Masaki, Hiroshi Hojo, et al.
International Journal of Cancer|November 1, 2013
High ubiquitous mitochondrial creatine kinase expression in hepatocellular carcinoma denotes a poor prognosis with highly malignant potentialBaasanjav Uranbileg, Kenichiro Enooku, Yoko Soroida, et al.
Pageof 25

Showing results (211-220 of 246) with videos related to

Sort By:
Pageof 25
Clinical Biochemistry|July 24, 2012
Development of an enzymatic assay for sphingomyelin with rapid and automatable performances: Analysis in healthy subjects and coronary heart disease patientsRyunosuke Ohkawa, Tatsuya Kishimoto, Makoto Kurano, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|May 28, 2014
Tumor markers are more useful in patients undergoing surveillance for hepatocellular carcinoma with unreliable results by ultrasonographyShintaro Mikami, Ryosuke Tateishi, Shu Hagiwara, et al.
Rapid Communications in Mass Spectrometry : RCM|August 15, 2019
Identification of novel biomarkers of hepatocellular carcinoma by high-definition mass spectrometry: Ultrahigh-performance liquid chromatography quadrupole time-of-flight mass spectrometry and desorption electrospray ionization mass spectrometry imagingKoshi Nagai, Baasanjav Uranbileg, Zhen Chen, et al.
Plos One|January 28, 2014
Detection of novel visible-light region absorbance peaks in the urine after alkalization in patients with alkaptonuriaYasunori Tokuhara, Kenichi Shukuya, Masami Tanaka, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 31, 2011
Prediction of hepatocellular carcinoma development by plasma ADAMTS13 in chronic hepatitis B and CHitoshi Ikeda, Ryosuke Tateishi, Kenichiro Enooku, et al.
Journal of Clinical Gastroenterology|June 20, 2007
Both plasma lysophosphatidic acid and serum autotaxin levels are increased in chronic hepatitis CNaoko Watanabe, Hitoshi Ikeda, Kazuhiro Nakamura, et al.
The EMBO Journal|June 8, 2017
Autotaxin-lysophosphatidic acid-LPA<sub>3</sub> signaling at the embryo-epithelial boundary controls decidualization pathwaysShizu Aikawa, Kuniyuki Kano, Asuka Inoue, et al.
Annals of Clinical and Translational Neurology|February 15, 2020
Nonmercaptalbumin as an oxidative stress marker in Parkinson's and PARK2 diseaseShin-Ichi Ueno, Taku Hatano, Ayami Okuzumi, et al.
Pediatric Blood & Cancer|July 4, 2025
Results of a Phase II Trial for Intermediate-Risk Rhabdomyosarcoma Treatment Protocol JRS-I: A Report From the Japan Rhabdomyosarcoma Study GroupAtsushi Kikuta, Hidekazu Masaki, Hiroshi Hojo, et al.
International Journal of Cancer|November 1, 2013
High ubiquitous mitochondrial creatine kinase expression in hepatocellular carcinoma denotes a poor prognosis with highly malignant potentialBaasanjav Uranbileg, Kenichiro Enooku, Yoko Soroida, et al.
Pageof 25